Open AccessProliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity
Author(s) -
Jerbi Mouna,
El Fatmi Rym,
Gaied Hanene,
Belloumi Dorra,
Torjemane Lamia,
Aoudia Raja,
Goucha Rim,
Abdallah Taieb Ben,
Othman Tarek Ben
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3439
Subject(s) - medicine , cyclophosphamide , glomerulonephritis , bortezomib , autologous stem cell transplantation , rapidly progressive glomerulonephritis , monoclonal antibody , monoclonal , dexamethasone , transplantation , antibody , treatment modality , immunology , pathology , multiple myeloma , chemotherapy , kidney
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits is a new disorder with undefined treatment modalities. We propose cyclophosphamide‐bortezomib‐dexamethasone and autologous stem cell transplantation as a therapeutic protocol.